Please use this identifier to cite or link to this item:
Appears in Collections:Faculty of Health Sciences and Sport Newspaper/Magazine Articles
Title: Three radical steps to derail doping in elite sport
Author(s): Dimeo, Paul
Issue Date: 12-Mar-2018
Publisher: The Conversation Trust
Citation: Dimeo P (2018) Three radical steps to derail doping in elite sport, The Conversation, 12.03.2018.
Abstract: First paragraph: Elite British cycling outfit Team Sky “crossed an ethical line” by giving medicines to squad members which could be used to enhance performance, according to the new UK parliamentary committee report into doping in British cycling and athletics. Though the report makes clear that the drug use was within global anti-doping rules, it devotes much attention to eight-times cycling medallist Bradley Wiggins and several occasions on which he took medicines before major races – he and Team Sky strenuously deny any wrongdoing.  Champion distance runner Mo Farah is also named. The report heavily criticises his doctor, Robin Chakraverty, for not recording the dose size of a restricted substance he injected into the athlete before the London Marathon in 2014 – Farah and Chakraverty insist they were within the rules. The report refers to “acute failures” in both British cycling and athletics around medicine procedures that urgently need addressed.
Type: Newspaper/Magazine Article
Rights: The Conversation uses a Creative Commons Attribution NoDerivatives licence. You can republish their articles for free, online or in print. Licence information is available at:
Affiliation: Sport

Files in This Item:
File Description SizeFormat 
Dimeo-Conversation-2018.pdfFulltext - Published Version1.58 MBAdobe PDFView/Open

This item is protected by original copyright

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact providing details and we will remove the Work from public display in STORRE and investigate your claim.